Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical Pharmacokinetics
Literature
1.
2.
Nakamura T, Kubota T, Iwakaji A, Imada M, Kapás M, Morio Y. Clinical pharmacology study of cariprazine (MP-214) in patients with schizophrenia (12-week treatment). Drug Des Devel Ther. 2016;10:327–38.CrossRef
3.
Allergan. VRAYLAR® (cariprazine). Full prescribing information. Allergan; 2019.
4.
5.
Carrothers T, Willavize S, Jaworowicz D, Passarell J, Periclou A, Ghahramani P, et al. Relationship of cariprazine plasma concentration to efficacy and safety in patients with schizophrenia or bipolar mania [poster]. American Psychiatric Association (APA) Annual Meeting; 14–18 May 2016; Atlanta.
6.
7.
Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry. 2018;51(1–02):9–62.PubMed
Metadata
Title
Comment on: “Clinical Pharmacokinetics of Atypical Antipsychotics: An Update”
Authors
Antonia Periclou
Todd Riccobene
Margit Kapás
István Laszlovszky
Publication date
01-09-2019
Publisher
Springer International Publishing
Published in
Clinical Pharmacokinetics / Issue 9/2019
Print ISSN: 0312-5963
Electronic ISSN: 1179-1926
DOI
https://doi.org/10.1007/s40262-019-00795-9

Other articles of this Issue 9/2019

Clinical Pharmacokinetics 9/2019 Go to the issue

Review Article

Clinical Pharmacokinetics and Pharmacodynamics of Eravacycline

Original Research Article

Pharmacokinetics and Safety of Olaparib in Patients with Advanced Solid Tumours and Renal Impairment

Letter to the Editor

Reply to Periclou et al.: “Clinical Pharmacokinetics of Atypical Antipsychotics: An Update”

Original Research Article

Assessment of Drug–Drug Interactions between Taspoglutide, a Glucagon-Like Peptide-1 Agonist, and Drugs Commonly Used in Type 2 Diabetes Mellitus: Results of Five Phase I Trials

Original Research Article

Population Pharmacokinetic and Pharmacodynamic Analysis of GLPG1690, an Autotaxin Inhibitor, in Healthy Volunteers and Patients with Idiopathic Pulmonary Fibrosis

Review Article

Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis